Company news

ScinoPharm Taiwan, Ltd. news in 2026

ScinoPharm Taiwan, Ltd.'s news releases, calls and decks from 2026, newest first.

View company

ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment of Multiple Sclerosis

January 5, 2026